Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Selective TACE inhibitor described as promising drug candidate and pharmacological tool

Sep. 6, 2001

Novel treatments for rheumatoid arthritis and other autoimmune diseases presented by Dainippon

Sep. 5, 2001

Novel therapeutic approach to autoimmune diseases identified by ZymoGenetics and Serono

Sep. 5, 2001

AtheroGenics files IND for intravenous AGIX-4207 to treat RA

Sep. 4, 2001

Two recent patents cover P2X7 receptor antagonists and their potential uses

Sep. 3, 2001

Potent and selective CCR2B receptor antagonist described by GlaxoSmithKline

Sep. 3, 2001

GW-432042: a potent and selective iNOS inhibitor debuts at ACS meeting

Sep. 3, 2001

Study questions cardiovascular safety of COX-2 inhibitors

Sep. 3, 2001

Uriach identifies UR-8880, its lead COX-2 inhibitor as a preclinical candidate

Aug. 31, 2001

Somatostatin analogue as a potential DMARD for patients with RA

Aug. 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...